CARGO Therapeutics is a biotechnology company focused on developing next-generation transformational CAR T-cell therapies with the mission of outsmarting cancer to deliver more cures for patients. They are engaged in innovative research and development of therapies targeting B-cell lymphoma and other cancer types, as demonstrated by their pipeline products like Firi-cel (CRG-022) and CRG-023. Their work is characterized by a robust focus on scientific discovery and collaboration within the biotechnology and pharmaceutical sectors.
51 - 200 employees
Founded 2021
𧬠Biotechnology
π Pharmaceuticals
π¬ Science
π₯ Funding within the last year
π° Post-IPO Equity on 2024-05
November 27
Drive multivariate data analysis efforts as Director of Computational Biology at CARGO Therapeutics.
πΊπΈ United States β Remote
π΅ $195k - $268k / year
π₯ Funding within the last year
π° Post-IPO Equity on 2024-05
β° Full Time
π΄ Lead
π Director